Money · Lobbying reports · 119th Congress
H.R. 10359
8 saved lobbying reports name H.R. 10359.
8 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read November 22, 2026 at 12:34 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | $200,000.00reported as expenses | July to September 2026 | Open the report | |
| AVENUE SOLUTIONS | OMEROS CORPORATION | $50,000.00reported as income | July to September 2026 | Open the report | |
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICS | $100,000.00reported as expenses | July to September 2026 | Open the report | |
| BRIDGEBIO PHARMA, INC. | BRIDGEBIO PHARMA, INC. | $510,000.00reported as expenses | July to September 2026 | Open the report | |
| THE NICKLES GROUP, LLC | OMEROS CORPORATION | $50,000.00reported as income | July to September 2026 | Open the report | |
| RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) | RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) | $60,000.00reported as expenses | July to September 2026 | Open the report | |
| RARE DISEASE COMPANY COALITION | RARE DISEASE COMPANY COALITION | $80,000.00reported as expenses | July to September 2026 | Open the report | |
| LUNDBECK LLC | LUNDBECK LLC | $130,000.00reported as expenses | July to September 2026 | Open the report |